Last reviewed · How we verify
NCT05562531
Botulinum Toxin Administration on Masticatory Performance
trial in Temporomandibular Disorder in 30 participants. Status unknown.
1 October 2023
Quick facts
| Lead sponsor | Marmara University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 May 2022 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
- Bruxism — all drugs for Bruxism →
Sponsor
Marmara University
Who can join
Adults 18 to 50, any sex, with Temporomandibular Disorder or Bruxism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to evaluate the effect of botulinum toxin type A (BTX-A) injection on masticatory performance and nutritional status in temporomandibular disorder patients with bruxism caused by both intra-articular and extra-articular pathologies based on Research Diagnostic Criteria for temporomandibular disorders (TMD). The baseline and end masticatory performance, pain intensity, nutrition and anxiety statuses, and anthropometric measurements will be compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05562531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other Marmara University trials
Trials by the same sponsor.
- NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
- NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
- NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05562531 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marmara University
- Last refreshed: 7 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05562531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing